CD4+CD25+Foxp3+ regulatory t cells are dispensable for controlling CD8+ T cell-mediated lung inflammation

Journal of Immunology

Volumn 186, Issue 11, 2011, Pages 6106-6118

  Tosiek, Milena J ^a   Gruber, Achim D ^b   Bader, Sophie R ^b   Mauel, Susanne ^b   Hoymann, Heinz Gerd ^c   Prettin, Silvia ^a   Tschernig, Thomas ^d   Buer, Jan ^e   Gereke, Marcus ^a   Bruder, Dunja ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

^d SAARLAND UNIVERSITY   (Germany)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD103 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR ALPHA; L SELECTIN; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; BRONCHUS LYMPH NODE; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DOWN REGULATION; EX VIVO STUDY; IMMUNOLOGICAL MEMORY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IN VITRO STUDY; LYMPH NODE; LYMPHATIC DRAINAGE; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PHENOTYPE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SPLEEN; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD; CD8-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION PROFILING; IMMUNE TOLERANCE; IMMUNOLOGIC MEMORY; INTEGRIN ALPHA CHAINS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; L-SELECTIN; LUNG; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PNEUMONIA; RESPIRATORY FUNCTION TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, REGULATORY;

EID: 79958040466     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000632     Document Type: Article

References (61)

1. Liblau, R. S., F. S. Wong, L. T. Mars, and P. Santamaria. 2002. Autoreactive CD8 T cells in organ-specific autoimmunity: emerging targets for therapeutic intervention. Immunity 17: 1-6. (Pubitemid 34874613)
2. Walter, U., and P. Santamaria. 2005. CD8+ T cells in autoimmunity. Curr. Opin. Immunol. 17: 624-631.
3. Costabel, U., and J. Guzman. 2001. Bronchoalveolar lavage in interstitial lung disease. Curr. Opin. Pulm. Med. 7: 255-261.
4. Newman, L. S., C. S. Rose, and L. A. Maier. 1997. Sarcoidosis. N. Engl. J. Med. 336: 1224-1234.
5. Prasse, A., C. G. Georges, H. Biller, H. Hamm, H. Matthys, W. Luttmann, and J. C. Virchow, Jr. 2000. Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells. Clin. Exp. Immunol. 122: 241-248.
6. Wahlström, J., K. Katchar, H. Wigzell, O. Olerup, A. Eklund, and J. Grunewald. 2001. Analysis of intracellular cytokines in CD4+ and CD8+ lung and blood T cells in sarcoidosis. Am. J. Respir. Crit. Care Med. 163: 115-121.
7. Enelow, R. I., A. Z. Mohammed, M. H. Stoler, A. N. Liu, J. S. Young, Y. H. Lou, and T. J. Braciale. 1998. Structural and functional consequences of alveolar cell recognition by CD8(+) T lymphocytes in experimental lung disease. J. Clin. Invest. 102: 1653-1661.
8. Borchers, M. T., S. C. Wesselkamper, V. Curull, A. Ramirez-Sarmiento, A. Sanchez-Font, J. Garcia-Aymerich, C. Coronell, J. Lloreta, A. G. Agusti, J. Gea, et al. 2009. Sustained CTL activation by murine pulmonary epithelial cells promotes the development of COPD-like disease. J. Clin. Invest. 119: 636-649.
9. Cha, S. I., M. B. Fessler, C. D. Cool, M. I. Schwarz, and K. K. Brown. 2006. Lymphoid interstitial pneumonia: clinical features, associations and prognosis. Eur. Respir. J. 28: 364-369.
10. Swigris, J. J., G. J. Berry, T. A. Raffin, and W. G. Kuschner. 2002. Lymphoid interstitial pneumonia: a narrative review. Chest 122: 2150-2164.
11. Fitzpatrick, E. A., M. Avdiushko, A. M. Kaplan, and D. A. Cohen. 1999. Role of T cell subsets in the development of AIDS-associated interstitial pneumonitis in mice. Exp. Lung Res. 25: 671-687.
12. Lairmore, M. D., J. M. Poulson, T. A. Adducci, and J. C. DeMartini. 1988. Lentivirus-induced lymphoproliferative disease. Comparative pathogenicity of phenotypically distinct ovine lentivirus strains. Am. J. Pathol. 130: 80-90.
13. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155: 1151-1164.
14. Sakaguchi, S. 2004. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22: 531-562.
15. Sakaguchi, S. 2005. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6: 345-352.
16. Zwar, T. D., I. R. van Driel, and P. A. Gleeson. 2006. Guarding the immune system: suppression of autoimmunity by CD4+CD25+ immunoregulatory T cells. Immunol. Cell Biol. 84: 487-501.
17. Barceló , B., J. Pons, J. M. Ferrer, J. Sauleda, A. Fuster, and A. G. Agustí. 2008. Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking. Eur. Respir. J. 31: 555-562.
18. Kearley, J., D. S. Robinson, and C. M. Lloyd. 2008. CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling. J. Allergy Clin. Immunol. 122: 617-624, e6.
19. Hartl, D., B. Koller, A. T. Mehlhorn, D. Reinhardt, T. Nicolai, D. J. Schendel, M. Griese, and S. Krauss-Etschmann. 2007. Quantitative and functional impairment of pulmonary CD4+CD25hi regulatory T cells in pediatric asthma. J. Allergy Clin. Immunol. 119: 1258-1266.
20. Isajevs, S., I. Taivans, G. Strazda, U. Kopeika, M. Bukovskis, V. Gordjusina, and A. Kratovska. 2009. Decreased FOXP3 expression in small airways of smokers with COPD. Eur. Respir. J. 33: 61-67.
21. Morgan, D. J., R. Liblau, B. Scott, S. Fleck, H. O. McDevitt, N. Sarvetnick, D. Lo, and L. A. Sherman. 1996. CD8(+) T cell-mediated spontaneous diabetes in neonatal mice. J. Immunol. 157: 978-983.
22. Kirberg, J., A. Baron, S. Jakob, A. Rolink, K. Karjalainen, and H. von Boehmer. 1994. Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor. J. Exp. Med. 180: 25-34.
23. Bruder, D., A. M. Westendorf, R. Geffers, A. D. Gruber, M. Gereke, R. I. Enelow, and J. Buer. 2004. CD4 T Lymphocyte-mediated lung disease: steady state between pathological and tolerogenic immune reactions. Am. J. Respir. Crit. Care Med. 170: 1145-1152.
24. Glaab, T., W. Mitzner, A. Braun, H. Ernst, R. Korolewitz, J. M. Hohlfeld, N. Krug, and H. G. Hoymann. 2004. Repetitive measurements of pulmonary mechanics to inhaled cholinergic challenge in spontaneously breathing mice. J. Appl. Physiol. 97: 1104-1111.
25. Hoymann, H. G. 2006. New developments in lung function measurements in rodents. Exp. Toxicol. Pathol. 57(Suppl 2): 5-11.
26. Chiavolini, D., J. Rangel-Moreno, G. Berg, K. Christian, L. Oliveira-Nascimento, S. Weir, J. Alroy, T. D. Randall, and L. M. Wetzler. 2010. Bronchus-associated lymphoid tissue (BALT) and survival in a vaccine mouse model of tularemia. PLoS ONE 5: e11156.
27. Takahama, Y., E.W. Shores, and A. Singer. 1992. Negative selection of precursor thymocytes before their differentiation into CD4+CD8+ cells. Science 258: 653-656.
28. Cho, B. K., C. Wang, S. Sugawa, H. N. Eisen, and J. Chen. 1999. Functional differences between memory and naive CD8 T cells. Proc. Natl. Acad. Sci. USA 96: 2976-2981.
29. Badovinac, V. P., and J. T. Harty. 2006. Programming, demarcating, and manipulating CD8+ T-cell memory. Immunol. Rev. 211: 67-80.
30. Harty, J. T., and V. P. Badovinac. 2008. Shaping and reshaping CD8+ T-cell memory. Nat. Rev. Immunol. 8: 107-119.
31. Pihlgren, M., C. Arpin, T. Walzer, M. Tomkowiak, A. Thomas, J. Marvel, and P. M. Dubois. 1999. Memory CD44(int) CD8 T cells show increased proliferative responses and IFN-gamma production following antigenic challenge in vitro. Int. Immunol. 11: 699-706.
32. Kerdiles, Y. M., D. R. Beisner, R. Tinoco, A. S. Dejean, D. H. Castrillon, R. A. DePinho, and S. M. Hedrick. 2009. Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. Nat. Immunol. 10: 176-184.
33. Ouyang, W., O. Beckett, Q. Ma, J. H. Paik, R. A. DePinho, and M. O. Li. 2010. Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat. Immunol. 11: 618-627.
34. McNeill, A., E. Spittle, and B. T. Bäckström. 2007. Partial depletion of CD69low-expressing natural regulatory T cells with the anti-CD25 monoclonal antibody PC61. Scand. J. Immunol. 65: 63-69.
35. Onizuka, S., I. Tawara, J. Shimizu, S. Sakaguchi, T. Fujita, and E. Nakayama. 1999. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res. 59: 3128-3133. (Pubitemid 29316012)
36. Ellies, L. G., A. T. Jones, M. J. Williams, and H. J. Ziltener. 1994. Differential regulation of CD43 glycoforms on CD4+ and CD8+ T lymphocytes in graft-versus-host disease. Glycobiology 4: 885-893.
37. Huehn, J., K. Siegmund, J. C. Lehmann, C. Siewert, U. Haubold, M. Feuerer, G. F. Debes, J. Lauber, O. Frey, G. K. Przybylski, et al. 2004. Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J. Exp. Med. 199: 303-313.
38. Huehn, J., and A. Hamann. 2005. Homing to suppress: address codes for Treg migration. Trends Immunol. 26: 632-636. (Pubitemid 41628195)
39. Zhao, D., C. Zhang, T. Yi, C. L. Lin, I. Todorov, F. Kandeel, S. Forman, and D. Zeng. 2008. In vivo-activated CD103+CD4+ regulatory T cells ameliorate ongoing chronic graft-versus-host disease. Blood 112: 2129-2138.
40. Westendorf, A. M., D. Fleissner, S. Deppenmeier, A. D. Gruber, D. Bruder, W. Hansen, R. Liblau, and J. Buer. 2006. Autoimmune-mediated intestinal inflammation-impact and regulation of antigen-specific CD8+ T cells. Gastroenterology 131: 510-524. (Pubitemid 44142451)
41. Gereke, M., S. Jung, J. Buer, and D. Bruder. 2009. Alveolar type II epithelial cells present antigen to CD4(+) T cells and induce Foxp3(+) regulatory T cells. Am. J. Respir. Crit. Care Med. 179: 344-355.
42. Hadeiba, H., and R. M. Locksley. 2003. Lung CD25 CD4 regulatory T cells suppress type 2 immune responses but not bronchial hyperreactivity. J. Immunol. 170: 5502-5510.
43. Kreuwel, H. T., S. Aung, C. Silao, and L. A. Sherman. 2002. Memory CD8(+) T cells undergo peripheral tolerance. Immunity 17: 73-81.
44. Prlic, M., L. Lefrancois, and S. C. Jameson. 2002. Multiple choices: regulation of memory CD8 T cell generation and homeostasis by interleukin (IL)-7 and IL-15. J. Exp. Med. 195: F49-F52.
45. Homann, D., L. Teyton, and M. B. Oldstone. 2001. Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory. Nat. Med. 7: 913-919.
46. Sakaguchi, S., M. Toda, M. Asano, M. Itoh, S. S. Morse, and N. Sakaguchi. 1996. T cell-mediated maintenance of natural self-tolerance: its breakdown as a possible cause of various autoimmune diseases. J. Autoimmun. 9: 211-220. (Pubitemid 26163865)
47. Fontenot, J. D., and A. Y. Rudensky. 2005. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat. Immunol. 6: 331-337.
48. Comans-Bitter, W. M., R. de Groot, R. van den Beemd, H. J. Neijens, W. C. Hop, K. Groeneveld, H. Hooijkaas, and J. J. van Dongen. 1997. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J. Pediatr. 130: 388-393.
49. Hannet, I., F. Erkeller-Yuksel, P. Lydyard, V. Deneys, and M. DeBruyere. 1992. Developmental and maturational changes in human blood lymphocyte subpopulations. Immunol. Today 13: 215, 218.
50. Furtado, G. C., M. A. Curotto de Lafaille, N. Kutchukhidze, and J. J. Lafaille. 2002. Interleukin 2 signaling is required for CD4(+) regulatory T cell function. J. Exp. Med. 196: 851-857.
51. Lowenthal, J. W., P. Corthésy, C. Tougne, R. Lees, H. R. MacDonald, and M. Nabholz. 1985. High and low affinity IL 2 receptors: analysis by IL 2 dissociation rate and reactivity with monoclonal anti-receptor antibody PC61. J. Immunol. 135: 3988-3994. (Pubitemid 16250380)
52. Couper, K. N., D. G. Blount, J. B. de Souza, I. Suffia, Y. Belkaid, and E. M. Riley. 2007. Incomplete depletion and rapid regeneration of Foxp3+ regulatory T cells following anti-CD25 treatment in malaria-infected mice. J. Immunol. 178: 4136-4146.
53. Mahnke, K., E. Schmitt, L. Bonifaz, A. H. Enk, and H. Jonuleit. 2002. Immature, but not inactive: the tolerogenic function of immature dendritic cells. Immunol. Cell Biol. 80: 477-483.
54. Tang, Q., J. Y. Adams, A. J. Tooley, M. Bi, B. T. Fife, P. Serra, P. Santamaria, R. M. Locksley, M. F. Krummel, and J. A. Bluestone. 2006. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat. Immunol. 7: 83-92.
55. de Vries, V. C., A. Wasiuk, K. A. Bennett, M. J. Benson, R. Elgueta, T. J. Waldschmidt, and R. J. Noelle. 2009. Mast cell degranulation breaks peripheral tolerance. Am. J. Transplant. 9: 2270-2280.
56. Nauta, A. J., and W. E. Fibbe. 2007. Immunomodulatory properties of mesenchymal stromal cells. Blood 110: 3499-3506.
57. Grimbaldeston, M. A., S. Nakae, J. Kalesnikoff, M. Tsai, and S. J. Galli. 2007. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat. Immunol. 8: 1095-1104.
58. Klimiuk, P. A., J. J. Goronzy, and C. M. Weyand. 1999. IL-16 as an anti-inflammatory cytokine in rheumatoid synovitis. J. Immunol. 162: 4293-4299.
59. Little, F. F., J. de Bie, A. van Oosterhout, H. Kornfeld, D. M. Center, and W. W. Cruikshank. 2003. Immunomodulatory effect of interleukin-16 on allergic airway inflammation. Chest 123(3, Suppl): 431S-432S.
60. Gereke, M., L. Gröbe, S. Prettin, M. Kasper, S. Deppenmeier, A. D. Gruber, R. I. Enelow, J. Buer, and D. Bruder. 2007. Phenotypic alterations in type II alveolar epithelial cells in CD4+ T cell mediated lung inflammation. Respir. Res. 8: 47.
61. Feuerer, M., W. Jiang, P. D. Holler, A. Satpathy, C. Campbell, M. Bogue, D. Mathis, and C. Benoist. 2007. Enhanced thymic selection of FoxP3+ regulatory T cells in the NOD mouse model of autoimmune diabetes. Proc. Natl. Acad. Sci. USA 104: 18181-18186.